“retrophin” Archives

in
Entry Author Date Location
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails 08/22/19 San Diego
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More 01/04/19 National
“Pharma Bro” Martin Shkreli Gets Seven Years for Securities Fraud 03/09/18 New York
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
With Reverse Merger, Miragen to Go Public, Get $40M Boost From Investors 11/01/16 Boulder/Denver
Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results 09/07/16 San Diego
KaloBios Deals With Shkreli After Exiting Bankruptcy With New Cash 07/07/16 San Francisco
Fired From KaloBios, Shkreli Defends Himself Against Fraud Charges 12/21/15 National
The Day After His Arrest, Martin Shkreli Is Out At Turing Pharma 12/18/15 National
West Coast Bio Roundup: Shkreli Cuffed, KaloBios Halted & More 12/17/15 National
Even With New Crowdfunding Rules, No Easy Path Forward For Biotechs 11/03/15 National
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed 10/07/15 National
Shkreli Implodes And Provides Hillary A Perfect Medicare Moment 09/23/15 National
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Shkreli Leads $90M Round for New Startup, Turing Pharma 08/10/15 New York
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday 05/27/15 New York
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
West Coast Biotech Roundup: Amgen/deCODE, Calico, Orexigen & More 03/27/15 San Diego
With Asklepion Deal, Retrophin Gets a New Drug—And a Voucher 03/18/15 New York
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
Enumeral Raises $21.5M, Heads to the OTC Via Reverse Merger 08/04/14 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan 07/31/14 San Francisco
Page 1 of 2 next page »